Loading, Please wait ...
Amdocs Ltd.
DOX.NISIN: GB0022569080SEDOL: 2256908 |
Rating: BUY |
Target Price: 25.11 USD |
Investment Horizon: 6 to 12 months |
3Q 09 News Alert
Amdocs Ltd (Amdocs) reported weak 3Q 09 results with a y-o-y decline in revenues in line with Management guidance on account of the weak demand environment. For the near-to-medium term, on account of the ongoing economic slowdown resulting in tight corporate budgets and a delay in deal closings, revenue growth prospects are expected to remain weak, reflected in cautious Management guidance for 4Q 09. However, we expect service revenues to increase in the long run taking into account…
2Q 09 News Alert
Amdocs Ltd (Amdocs) reported a y-o-y decline in 2Q 09 revenues in line with Management guidance on account of the weak demand environment. However, top-line was reported marginally above our expectation on account of higher-than-estimated License revenues. Operating income and net income also surpassed our expectations on account of lower-than-expected cost of operations. Although we expect revenue growth prospects to be weak due to tight corporate budgets and delay in deal closings…
1Q 09 Update Report
Delay in deal closing rates on account of poor macro-economic conditions, aggravated by unfavorable currency movements have resulted in revenues falling short of our and Management’s expectations. The deal closing process is expected to be further elongated in FY 2009 in addition to low visibility on closure rates due to tight budgets. This is reflected in the 9%-12% y-o-y decline in revenue guidance provided by Management for FY 2009…
1Q 09 News Alert
CLICK VIEW REPORT TO READ FREE REPORT
Amdocs Ltd (Amdocs) reported a marginal y-o-y increase in 1Q 09 revenues. Top-line was below Management guidance, attributable to the decline in Service revenues. Operating income was also below our expectation on account of the lower than expected top-line performance. Earnings however, exceeded our estimate on account of the higher than expected interest income coupled with the lower than excepted tax charges. Based on…
4Q 08 Update Report
CLICK VIEW REPORT TO READ FREE REPORT
While Amdocs Ltd.’s (Amdocs) 4Q 08 top-line was in line with our expectation, earnings fell marginally below our expectations due to higher-than-anticipated interest expenses. While revenues and operating income registered healthy y-o-y growth, net income declined as a result of higher interest expenses. FY 2008 performance remained healthy at all levels. Management expects declining revenues due to unfavorable currency…
Subscribe to Alerts
Sign up for a free account to receive email alerts for this stockMore Information
Request a redistribution license
Access to short term actionable trading strategies
(available only with Global Research subscription)
Access to financial models
(available only with Global Research subscription)
